PRINCETON, N.J., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the "Company” or "Sonnet”) (NASDAQ: SONN), a clinical-stage company developing targeted immunotherapeutic ...
Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback